Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...

Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.

We recently compiled a list of the 10 Oversold Global Stocks To Buy Right Now. In this article, we are going to take a look at where Silence Therapeutics plc (NASDAQ:SLN) stands against the other ...

The latest price target for Silence Therapeutics (NASDAQ:SLN) was reported by HC Wainwright & Co. on September 16, 2025. The analyst firm set a price target for $75.00 expecting SLN to rise to within ...

Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...

When teaching depreciation in Introduction to Accounting, faculty always cover a variety of different depreciation methods, including straight-line depreciation. Next time you teach this topic, build ...

Take advantage of real dealer pricing and shop special offers on new and used boats. Select your boat to get started. A boat's history affects it's value—check the history of this 2016 Sea Ray Boats ...

PARIS, Feb 13 (Reuters) - The French government has agreed to grant a 40 million euro ($42.9 million) loan to SLN, the New Caledonian nickel producer controlled by mining group Eramet (ERMT.PA), opens ...

Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...